Podcast: Breast Tomosynthesis — One Practice's Experience
In this podcast, Stephen Rose, MD, president and CEO of Houston Breast Imaging and a principal investigator of the 3-D tomosynthesis clinical trials in 2010, discusses the benefits of the new technology and what his practice learned when implementing the screening program.
Breast Cancer Screening Recs: A Review of Recent Articles and Position Statements
The newest recommendations issued by the USPSTF resulted in confusion for both physicians and patients. Many experts in the field of breast imaging have come out both in support of and in opposition to the new recommendations.
Beyond the Mammogram: Molecular Breast Imaging Emerges
Enter nuclear breast imaging, the catch-all phrase for several modalities that use a radiopharmaceutical agent in scanning, including gamma imaging and positron emission mammography (PEM). Known as both molecular breast imaging (MBI) and breast-specific gamma imaging (BSGI), the gamma cameras are an adjunctive technology for suspicious lesions found during mammogram.
Related Article: Introducing Whole Breast Ultrasound
CAD Ineffective, Counterproductive for Breast Cancer Patients
Computer-aided detection (CAD) technology fails to spot breast tumors and increases a woman's risk of being called back for needless post-mammography testing, according to a new study published online today in the Journal of the National Cancer Institute.
MRI Plus Mammography Finds More Cancers After Chest Irradiation
An MRI scan in addition to mammography detects more breast cancers in women who underwent therapeutic chest radiation as children or young adults, than either modality alone, according a new study released this week in Radiology.